|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-11-13
|
|
pubmed:abstractText |
Alfuzosin 10mg is a uroselective alpha(1)-adrenoceptor antagonist used to treat lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Recent studies have suggested the potential efficacy of alfuzosin in the treatment of distal ureteral stones and prostatitis syndrome, two conditions frequently encountered in young patients. The objective of this study was to evaluate the effect of 10mg alfuzosin on blood pressure (BP) and heart rate (HR) in young healthy volunteers.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0302-2838
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1292-6; discussion 1297-8
|
|
pubmed:meshHeading |
pubmed-meshheading:16837126-Adrenergic alpha-Antagonists,
pubmed-meshheading:16837126-Adult,
pubmed-meshheading:16837126-Blood Pressure,
pubmed-meshheading:16837126-Cross-Over Studies,
pubmed-meshheading:16837126-Dose-Response Relationship, Drug,
pubmed-meshheading:16837126-Double-Blind Method,
pubmed-meshheading:16837126-Follow-Up Studies,
pubmed-meshheading:16837126-Heart Rate,
pubmed-meshheading:16837126-Humans,
pubmed-meshheading:16837126-Male,
pubmed-meshheading:16837126-Prognosis,
pubmed-meshheading:16837126-Prostatitis,
pubmed-meshheading:16837126-Quinazolines,
pubmed-meshheading:16837126-Reference Values,
pubmed-meshheading:16837126-Ureteral Calculi
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Alfuzosin (10 mg) does not affect blood pressure in young healthy men.
|
|
pubmed:affiliation |
Urology Division, S. Maria Annunziata Hospital, University of Florence, Florence, Italy. nicola.mondaini@unifi.it <nicola.mondaini@unifi.it>
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
